During the past decade, National Hospital Organization Toneyama National Hospital conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 5 clinical trials were completed, i.e. on average, 55.6% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 5 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "National Hospital Organization Toneyama National Hospital" #1 sponsor was "AstraZeneca" with 2 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Japan Clinical Oncology Group" with 2 trials sponsored and "Mitsubishi Tanabe Pharma America Inc." with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Hospital Organization Toneyama National Hospital" #1 collaborator was "Ministry of Health, Labour and Welfare, Japan" with 3 trials as a collaborator and "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "National Hospital Organization Toneyama National Hospital" are "Carcinoma, Non-Small-Cell Lung" (2 trials), "ALS" (1 trials), "Advanced or Metastatic Non-small Cell Lung Cancer" (1 trials), "Alzheimer's Disease" (1 trials) and "Alzheimer´s Disease" (1 trials). Many other conditions were trialed in "National Hospital Organization Toneyama National Hospital" in a lesser frequency.

Most popular intervention types in "National Hospital Organization Toneyama National Hospital" are "Drug" (12 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Lanabecestat" (2 trials), "Lazertinib" (2 trials), "MT-1186" (2 trials), "Placebo" (2 trials) and "Amivantamab" (1 trials). Other intervention names were less common.

The vast majority of trials in "National Hospital Organization Toneyama National Hospital" are 11 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "National Hospital Organization Toneyama National Hospital". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in National Hospital Organization Toneyama National Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in National Hospital Organization Toneyama National Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".